Evidence map›Paper›PMID 36964041›Full record

ArticleEuropean urology2023

Erratum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [Eur Urol 2023;83(3):224-38].

Christina Guo, Ines Figueiredo, Bora Gurel, Antje Neeb, George Seed, Mateus Crespo, Suzanne Carreira, Jan Rekowski, Lorenzo Buroni, Jon Welti and 23 more

Open access · hybridAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in European urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors at 8 institutions in 4 countries.

Christina GuoThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
Ines FigueiredoThe Institute of Cancer Research, London, UK.
Bora GurelThe Institute of Cancer Research, London, UK.
Antje NeebThe Institute of Cancer Research, London, UK.
George SeedThe Institute of Cancer Research, London, UK.
Mateus CrespoThe Institute of Cancer Research, London, UK.
Suzanne CarreiraThe Institute of Cancer Research, London, UK.
Jan RekowskiThe Institute of Cancer Research, London, UK.
Lorenzo BuroniThe Institute of Cancer Research, London, UK.
Jon WeltiThe Institute of Cancer Research, London, UK.
Denisa BogdanThe Institute of Cancer Research, London, UK.
Lewis GallagherThe Institute of Cancer Research, London, UK.
Adam SharpThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
Maria D Fenor de la MazaThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
Pasquale RescignoCandiolo Cancer Institute, FPO-IRCCS, Candiolo TO, Italy.
Daniel WestabyThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
Khobe ChandranThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
Ruth RiisnaesThe Institute of Cancer Research, London, UK.
Ana FerreiraThe Institute of Cancer Research, London, UK.
Susana MirandaThe Institute of Cancer Research, London, UK.
Bianca CalìInstitute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland.
Andrea AlimontiInstitute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland; Veneto Institute of Molecular Medicine, Padova, Italy.
Silvia BressanInstitute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Alana H T NguyenColumbia University Irving Medical Center, New York, NY, USA.
Michael M ShenColumbia University Irving Medical Center, New York, NY, USA.
Jessica E HawleyColumbia University Irving Medical Center, New York, NY, USA; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Aleksandar ObradovicColumbia University Irving Medical Center, New York, NY, USA.
Charles G DrakeColumbia University Irving Medical Center, New York, NY, USA; Janssen Research, Spring House, PA, USA.
Claudia BertanThe Institute of Cancer Research, London, UK.
Chloe BakerThe Institute of Cancer Research, London, UK.
Nina TunariuThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
Wei YuanThe Institute of Cancer Research, London, UK.
Johann S de BonoThe Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.
Institute of Cancer Research · GBColumbia University Irving Medical Center · USRoyal Marsden NHS Foundation Trust · GBInstitute of Oncology Research · CHFred Hutch Cancer Center · USIstituti di Ricovero e Cura a Carattere Scientifico · ITJanssen (United States) · USUniversità della Svizzera italiana · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36964041
OpenAlexW4353048864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.